← back to search

Père-Joan Cardona

Universitat Autònoma de Barcelona · ES
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Infectious Diseases and Tuberculosis, and Diagnosis and treatment of tuberculosis.
h-index
52
citations
10,395
works
253
NIH funding
primary concept
Medicine
email

Recent publications

A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.
2026cited by 1position: contributordoi
Fluorescence-based index from the Sofia <i>Streptococcus pneumoniae</i> fluorescent immunoassay: a prognostic tool for pneumococcal community-acquired pneumonia.
2026cited by 0position: contributordoi
Tuberculosis outbreak in a pre-primary and primary school in Barcelona, Spain.
2026cited by 0position: contributordoi
Population structure and spatial distribution of <i>Mycobacterium tuberculosis</i> complex in Catalonia.
2026cited by 0position: contributordoi
Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients.
2026cited by 0position: contributordoi
Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications.
2025cited by 9position: contributordoi
Genome-wide phenotypic insights into mycobacterial virulence using Drosophila melanogaster.
2025cited by 2position: contributordoi
Cross-border investigation of a tuberculosis outbreak in Vienna linked to a multi-country cluster among foreign-born individuals, Europe, 2021 to 2025
Eurosurveillance 2025cited by 2position: contributordoi
Fourier-transform infrared spectroscopy for rapid <i>Streptococcus pneumoniae</i> serotyping in a tertiary care general hospital.
2025cited by 1position: contributordoi
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.
2025cited by 1position: contributordoi
Bacteriology of Anorectal Abscess and Anal Fistula: A Systematic Review of the Literature.
2025cited by 0position: contributordoi
Safety and immunomodulatory efficacy of heat-killed <i>Mycolicibacterium manresensis</i> as a novel paraprobiotic in swine.
2025cited by 0position: contributordoi
Performance (Sensitivity and Specificity) of a New Point-of-Care Immunochromatography to Screen for Imported Chronic Schistosomiasis Among Long-Term Sub-Saharan Migrants.
2025cited by 0position: contributordoi
Rapid Detection of VREfm Clusters: FTIR Spectroscopy as a Practical Alternative to Whole-Genome Sequencing.
2025cited by 0position: contributordoi
Evaluation of two SARS-CoV-2 whole genome amplification and sequencing workflows for genomic surveillance and outbreak analysis in the clinical microbiology laboratory.
2025cited by 0position: contributordoi
Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study.
2025cited by 0position: contributordoi
Acetylsalicylic Acid and Ibuprofen as Adjunctive Therapy for Tuberculosis
2025cited by 0position: contributordoi
Usefulness of Dried Blood Spot Samples for Syphilis Screening
LabMed 2025cited by 0position: contributordoi
Executive Summary: Clinical Practice Guidelines on the Management of Resistant Tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).
2024cited by 4position: contributordoi
Country-report pattern corrections of new cases allow accurate 2-week predictions of COVID-19 evolution with the Gompertz model.
2024cited by 4position: contributordoi
A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings.
2024cited by 4position: contributordoi
<i>Drosophila melanogaster</i> experimental model to test new antimicrobials: a methodological approach.
2024cited by 3position: contributordoi
Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights.
2024cited by 3position: contributordoi
<i>Candida albicans</i> infection model in <i>Drosophila melanogaster</i> suggests a strain-specific virulent factor boosting a stormy innate immune response.
2024cited by 2position: contributordoi
Analysis of a Large Severe Acute Respiratory Syndrome Coronavirus 2 (Alpha) Outbreak in a Catalan Prison Using Conventional and Genomic Epidemiology.
2024cited by 2position: contributordoi
Evaluation of the Vitros® Anti-T. cruzi assay for its incorporation into the <i>Trypanosoma cruzi</i> infection diagnostic algorithm.
2024cited by 0position: contributordoi
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.
2023cited by 127position: contributordoi
Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain.
2023cited by 20position: contributordoi
Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox.
2023cited by 11position: contributordoi
Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
2023cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 29 papers (2020–2026)Cris Vilaplana · Institut Català de la Salut15 papers (2019–2025)Ignacio Blanco · Institut Català de la Salut10 papers (2022–2025)Clara Prats · Universitat Politècnica de Catalunya6 papers (2020–2023)Martí Català · University of Oxford6 papers (2020–2023)Gema Fernández-Rivas · Hospital Universitari Germans Trias i Pujol5 papers (2023–2025)Bonaventura Clotet · Directorate of Health3 papers (2022–2025)Enrique Alvarez-Lacalle · Universitat Politècnica de Catalunya3 papers (2020–2020)Nuria Izquierdo-Useros · Instituto de Investigación de Enfermedades Raras3 papers (2021–2023)Lilibeth Arias · Instituto de Salud Carlos III3 papers (2022–2025)Marta Massanella · Instituto de Investigación de Enfermedades Raras3 papers (2022–2025)Sergio Alonso · Universitat Politècnica de Catalunya3 papers (2020–2020)Carolina Armengol · Ludwig-Maximilians-Universität München3 papers (2021–2025)Roger Paredes · Rice University3 papers (2023–2026) · 3 papers (2022–2025)Pablo L. Ortiz‐Romero · Universidad Complutense de Madrid2 papers (2023–2023)Juan F. Arenillas · Hospital Clínico Universitario de Valladolid2 papers (2021–2021)Jordi Casabona · Departamento de Salud2 papers (2023–2023)Andrea Zelmer · London School of Hygiene & Tropical Medicine2 papers (2015–2019)Dominic Habgood-Coote · The London College2 papers (2022–2025)